Drug Type ASO |
Synonyms- |
Target |
Action inhibitors |
Mechanism KDM1A inhibitors(Lysine-specific histone demethylase 1 inhibitors), PRMT6 inhibitors(protein arginine methyltransferase 6 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bulbo-Spinal Atrophy, X-Linked | Discovery | - | 27 Jun 2024 | |
Bulbo-Spinal Atrophy, X-Linked | Discovery | - | 27 Jun 2024 | |
Bulbo-Spinal Atrophy, X-Linked | Discovery | - | 27 Jun 2024 | |
Bulbo-Spinal Atrophy, X-Linked | Discovery | - | 27 Jun 2024 | |
Bulbo-Spinal Atrophy, X-Linked | Discovery | - | 27 Jun 2024 | |
Neoplasms | Discovery | - | 27 Jun 2024 | |
Neoplasms | Discovery | - | 27 Jun 2024 | |
Neoplasms | Discovery | - | 27 Jun 2024 | |
Neoplasms | Discovery | - | 27 Jun 2024 | |
Neoplasms | Discovery | - | 27 Jun 2024 |